| Field | Specification |
|---|---|
| Mfr No | |
| Alternative Names | Pygopus homolog 2;PYGO2;PP7910; |
| Cellular Localization | |
| Clonality | |
| Concentration | |
| Gene ID | |
| Host | |
| Immunogen | A synthesized peptide derived from human PPP6C |
| Isotype | |
| Molecular Weight | |
| Product Type | |
| Reactivity | |
| Reconstitution | |
| Target | |
| UniProt # |
Boster Bio Anti-PPP6C Rabbit Monoclonal Antibody catalog # M05295. Tested in WB, ICC/IF, Flow Cytometry applications. This antibody reacts with Human.
Protein: T-cell surface glycoprotein CD3 zeta chain | Gene: Pygopus homolog 2 | Target: PPP6C | Function: Involved in signal transduction through the Wnt pathway. | Research areas: Domain Families,Epigenetics and Nuclear Signaling,Nuclear,Signaling Pathways,Stem Cells,Transcription,Zinc Finger
Host: Rabbit | Clonality/Clone: Monoclonal / Clone: 27P53 | Isotype: IgG | Reactivity: Human | Immunogen: A synthesized peptide derived from human PPP6C | Concentration: 0.5mg/ml | Purification: Affinity-chromatography
Applications: WB, IF, ICC, FC
Observed MW: 32 kDa | Calculated MW: 41244 MW
Cellular localization: Nucleus .
Tissue details: Expressed in barely detectable amounts in most tissues except brain, highest levels being found in lung, liver and skeletal muscle.
Status: Active
Customization & Add-ons: Can’t find the antibody you need—or require a custom format for your assay? We can help you source the best match or support custom antibody solutions for diverse research needs, including species and isotype selection, conjugations and labeling (e.g., HRP/AP, biotin, fluorophores), purification grade options (Protein A/G, affinity purified), formulation preferences (buffer selection, carrier-free, glycerol-free), custom concentrations and aliquoting, low-endotoxin options for cell-based work, and application-focused QC/validation support (project dependent). Click Talk to a Scientist to submit a request, email us at support@biohippo.com, or explore our Research Services for additional support—our team will follow up with feasibility details and next steps.
